These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 27618750)

  • 1. Management of Rectal Cancer Without Radical Resection.
    Beets GL; Figueiredo NF; Beets-Tan RG
    Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
    Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation.
    Habr-Gama A; Lynn PB; Jorge JM; São Julião GP; Proscurshim I; Gama-Rodrigues J; Fernandez LM; Perez RO
    Dis Colon Rectum; 2016 Apr; 59(4):264-9. PubMed ID: 26953984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.
    Martens MH; Maas M; Heijnen LA; Lambregts DM; Leijtens JW; Stassen LP; Breukink SO; Hoff C; Belgers EJ; Melenhorst J; Jansen R; Buijsen J; Hoofwijk TG; Beets-Tan RG; Beets GL
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27509881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection - A Matched-Controlled Study.
    Hupkens BJP; Martens MH; Stoot JH; Berbee M; Melenhorst J; Beets-Tan RG; Beets GL; Breukink SO
    Dis Colon Rectum; 2017 Oct; 60(10):1032-1040. PubMed ID: 28891846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
    Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
    JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a place for organ preservation in infiltrating rectal cancer?
    Manceau G; Panis Y
    Minerva Chir; 2015 Aug; 70(4):283-96. PubMed ID: 25897587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in organ preserving strategies in rectal cancer patients.
    Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
    Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal.
    Peltrini R; Sacco M; Luglio G; Bucci L
    Updates Surg; 2020 Mar; 72(1):29-37. PubMed ID: 31621033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
    São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
    Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organ preserving strategies for rectal cancer treatment].
    Vendrely V; Denost Q; Amestoy F; Célérier B; Smith D; Rullier A; Rullier É
    Cancer Radiother; 2015 Oct; 19(6-7):404-9. PubMed ID: 26278990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches.
    Bach SP;
    Colorectal Dis; 2022 May; 24(5):639-651. PubMed ID: 35114057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility Scores and Preferences for Surgical and Organ-Sparing Approaches for Treatment of Intermediate and High-Risk Rectal Cancer.
    Couwenberg AM; Intven MPW; Burbach JPM; Emaus MJ; van Grevenstein WMU; Verkooijen HM
    Dis Colon Rectum; 2018 Aug; 61(8):911-919. PubMed ID: 29697477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ preservation in rectal cancer: have all questions been answered?
    Marijnen CA
    Lancet Oncol; 2015 Jan; 16(1):e13-22. PubMed ID: 25638548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada.
    Crawford A; Firtell J; Caycedo-Marulanda A
    J Gastrointest Cancer; 2019 Jun; 50(2):260-268. PubMed ID: 29388060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we
    Rombouts AJM; Al-Najami I; Abbott NL; Appelt A; Baatrup G; Bach S; Bhangu A; Garm Spindler KL; Gray R; Handley K; Kaur M; Kerkhof E; Kronborg CJ; Magill L; Marijnen CAM; Nagtegaal ID; Nyvang L; Peters FP; Pfeiffer P; Punt C; Quirke P; Sebag-Montefiore D; Teo M; West N; de Wilt JHW;
    BMJ Open; 2017 Dec; 7(12):e019474. PubMed ID: 29288190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can less be more? Organ preservation strategies in the management of rectal cancer.
    Rouleau-Fournier F; Brown CJ
    Curr Oncol; 2019 Nov; 26(Suppl 1):S16-S23. PubMed ID: 31819706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.